Chunghwa Chemical Synthesis & Biotech Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chunghwa Chemical Synthesis & Biotech Co Ltd with three other
companies in this sector in Taiwan:
Panion & Bf Biotech Inc.
sales of 1.05 billion Taiwanese Dollars [US$35.50 million]
of which 70%
Syngen Biotech Co Ltd
(769.37 million Taiwanese Dollars [US$26.03 million]
Savior Lifetec Corp
(1.53 billion Taiwanese Dollars [US$51.83 million]
of which 100%
was Drugs Development, Production and Sales).
During the year ended December of 2016, sales at
Chunghwa Chemical Synthesis & Biotech Co Ltd were 1.20 billion Taiwanese Dollars (US$40.55 million).
increase of 3.1%
versus 2015, when the company's sales were 1.16 billion Taiwanese Dollars.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Chunghwa Chemical Synthesis & Biotech Co Ltd had sales
of 1.20 billion Taiwanese Dollars.
Sales of Taiwan saw an increase
that was more than double the company's growth rate: sales were up
10.2% in 2016, from
510.88 million Taiwanese Dollars to 563.00 million Taiwanese Dollars.
Not all segments of Chunghwa Chemical Synthesis & Biotech Co Ltd experienced an increase in sales in 2016:
sales of Usa fell 2.4% to 635.67 million Taiwanese Dollars.